• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    7/10/23 1:50:32 PM ET
    $STRC
    $TCBP
    $TEAF
    $TGL
    Wholesale Distributors
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $STRC alert in real time by email

     

    On Monday, 65 companies hit new 52-week lows.

    Things to Consider About Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Pfizer (NYSE:PFE).
    • The smallest company in terms of market cap to set a new 52-week low was Biodexa Pharmaceuticals (NASDAQ:BDRX).
    • Tivic Health Systems (NASDAQ:TIVC) shares traded down 40.69% to reach its 52-week low, making it the biggest loser.
    • Chijet Motor Co (NASDAQ:CJET) shares bounced back the most, actually rising 0.0% after hiting a new 52-week low.

    Stocks dropping to new 52-week lows on Monday:

    • Bristol-Myers Squibb (NYSE:BMY) shares fell to $62.30 on Monday, setting a new 52-week low with a shift of down 0.54%.
    • Humana (NYSE:HUM) shares reached a new 52-week low of $427.21 on Monday morning, moving up 0.06%.
    • Amcor (NYSE:AMCR) stock hit a new 52-week low of $9.48. The stock was down 3.77% on the session.
    • FMC (NYSE:FMC) stock hit $88.80 on Monday morning, setting a new 52-week low for a change of down 14.62%.
    • KT (NYSE:KT) shares fell to $11.10 on Monday, setting a new 52-week low with a shift of up 0.04%.
    • UGI (NYSE:UGI) shares were down 0.81% for the day, having made a 52-week low of $25.69.
    • Clearway Energy (NYSE:CWEN) shares moved down 0.29% on Monday to hit a new 52-week low of $27.38, drifting down 0.29%.
    • California Water Servs Gr (NYSE:CWT) shares set a new yearly low of $49.27 this morning. The stock was down 0.37% on the session.
    • SunPower (NASDAQ:SPWR) stock hit a new 52-week low of $8.99. The stock was up 1.49% on the session.
    • Northwest Natural Hldg (NYSE:NWN) shares reached a new 52-week low of $41.64 on Monday morning, moving up 0.12%.
    • Duckhorn Portfolio (NYSE:NAPA) stock broke to a new 52-week low of $12.54 on Monday. Shares of the company traded down 1.41%.
    • Kenon Hldgs (NYSE:KEN) stock achieved a new 52-week low on Monday morning, hitting $22.85 and moving down 2.52%.
    • Enanta Pharma (NASDAQ:ENTA) shares were up 1.69% for the day, having made a 52-week low of $19.29.
    • Chijet Motor Co (NASDAQ:CJET) stock achieved a new 52-week low on Monday morning, hitting $2.31 and moving 0.0% (flat).
    • First Foundation (NASDAQ:FFWM) shares made a new 52-week low of $3.75 on Monday. The stock was down 0.52% for the day.
    • Douglas Elliman (NYSE:DOUG) shares were up 5.6% for the day, having made a 52-week low of $2.07.
    • Tortoise Essential Assets (NYSE:TEAF) shares moved down 0.32% on Monday to hit a new 52-week low of $12.20, drifting down 0.32%.
    • Delaware Inv Natl Muni (AMEX:VFL) shares fell to $9.85 on Monday, setting a new 52-week low with a shift of down 0.2%.
    • OptiNose (NASDAQ:OPTN) stock hit $1.05 on Monday morning, setting a new 52-week low for a change of down 4.02%.
    • Cherry Hill Mortgage (NYSE:CHMI) shares fell to $4.33 on Monday, setting a new 52-week low with a shift of down 0.23%.
    • Meihua Intl Medical Techs (NASDAQ:MHUA) shares moved up 1.24% on Monday to hit a new 52-week low of $2.38, drifting up 1.24%.
    • Jerash Holdings (US) (NASDAQ:JRSH) stock dropped to a yearly low on Monday of $3.64. Shares traded down 1.35%.
    • 22nd Century Group (NASDAQ:XXII) shares hit a yearly low of $2.42. The stock was down 7.47% on the session.
    • Interactive Strength (NASDAQ:TRNR) shares fell to $2.49 on Monday, setting a new 52-week low with a shift of up 3.44%.
    • Sarcos Technology (NASDAQ:STRC) stock hit $1.46 on Monday morning, setting a new 52-week low for a change of down 6.23%.
    • Yunji (NASDAQ:YJ) stock hit a new 52-week low of $1.27. The stock was down 7.64% on the session.
    • Psychemedics (NASDAQ:PMD) shares set a new 52-week low of $4.19. The stock traded up 0.46%.
    • Tattooed Chef (NASDAQ:TTCF) shares reached a new 52-week low of $0.21 on Monday morning, moving down 11.54%.
    • Powerbridge Technologies (NASDAQ:PBTS) stock hit $0.61 on Monday morning, setting a new 52-week low for a change of down 2.25%.
    • Cineverse (NASDAQ:CNVS) stock hit a yearly low of $1.53. The stock was down 3.4% for the day.
    • Treasure Global (NASDAQ:TGL) shares fell to $0.90 on Monday, setting a new 52-week low with a shift of down 3.29%.
    • Avalon Globocare (NASDAQ:ALBT) stock set a new 52-week low of $1.19 on Monday, moving up 6.19%.
    • ABVC BioPharma (NASDAQ:ABVC) shares set a new 52-week low of $0.44. The stock traded down 2.06%.
    • FOXO Technologies (AMEX:FOXO) shares moved down 7.27% on Monday to hit a new 52-week low of $0.18, drifting down 7.27%.
    • Greenwave Tech Solns (NASDAQ:GWAV) stock dropped to a yearly low on Monday of $0.70. Shares traded down 3.1%.
    • T Stamp (NASDAQ:IDAI) shares were down 5.37% for the day, having made a 52-week low of $0.96.
    • iSun (NASDAQ:ISUN) shares set a new 52-week low of $0.37. The stock traded down 1.19%.
    • Ault Alliance (AMEX:AULT) shares fell to $4.86 on Monday, setting a new 52-week low with a shift of down 1.78%.
    • Enservco (AMEX:ENSV) stock broke to a new 52-week low of $0.29 on Monday. Shares of the company traded up 2.07%.
    • OceanPal (NASDAQ:OP) stock broke to a new 52-week low of $1.26 on Monday. Shares of the company traded down 7.56%.
    • SuperCom (NASDAQ:SPCB) shares made a new 52-week low of $0.92 on Monday. The stock was up 0.36% for the day.
    • Ra Medical Systems (AMEX:RMED) shares set a new 52-week low of $0.70. The stock traded down 5.47%.
    • Gaucho Group Holdings (NASDAQ:VINO) shares moved up 1.99% on Monday to hit a new 52-week low of $0.50, drifting up 1.99%.
    • Blue Star Foods (NASDAQ:BSFC) stock hit a new 52-week low of $1.05. The stock was down 5.65% on the session.
    • Ucommune International (NASDAQ:UK) shares made a new 52-week low of $0.50 on Monday. The stock was up 1.63% for the day.
    • G Medical Innovations (NASDAQ:GMVD) shares made a new 52-week low of $0.32 on Monday. The stock was up 1.73% for the day.
    • TC BioPharm (Holdings) (NASDAQ:TCBP) shares set a new 52-week low of $0.43. The stock traded down 1.97%.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares were down 2.76% for the day, having made a 52-week low of $3.76.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $STRC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STRC
    $TCBP
    $TEAF
    $TGL

    CompanyDatePrice TargetRatingAnalyst
    Clearway Energy Inc.
    $CWEN
    12/17/2025$38.00Neutral → Sector Outperform
    CIBC
    Bristol-Myers Squibb Company
    $BMY
    12/15/2025$61.00Neutral → Buy
    BofA Securities
    Bristol-Myers Squibb Company
    $BMY
    12/12/2025$62.00Neutral → Buy
    Guggenheim
    FMC Corporation
    $FMC
    12/9/2025$13.00Equal Weight → Underweight
    Barclays
    Humana Inc.
    $HUM
    12/5/2025$313.00Hold → Buy
    Jefferies
    Pfizer Inc.
    $PFE
    12/2/2025$26.00Neutral
    Citigroup
    Enanta Pharmaceuticals Inc.
    $ENTA
    11/14/2025Overweight
    Analyst
    Pfizer Inc.
    $PFE
    11/13/2025$30.00Sector Outperform
    Scotiabank
    More analyst ratings

    $STRC
    $TCBP
    $TEAF
    $TGL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 25, 2024 - FDA Roundup: October 25, 2024

    For Immediate Release: October 25, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated the advisory for the outbreak of E. coli O157:H7. A specific ingredient has not yet been confirmed as the source of the outbreak, but most sick people report eating McDonald’s Quarter Pounder burgers. Investigators are working to deter

    10/25/24 2:48:21 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for HYMPAVZI issued to PFIZER INC

    Submission status for PFIZER INC's drug HYMPAVZI (ORIG-1) with active ingredient MARSTACIMAB-HNCQ has changed to 'Approval' on 10/11/2024. Application Category: BLA, Application Number: 761369, Application Classification:

    10/15/24 2:57:27 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    October 11, 2024 - FDA Approves New Treatment for Hemophilia A or B

    For Immediate Release: October 11, 2024 Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors (neutralizing antibodies). “Today’s approval of Hympavzi pro

    10/11/24 2:12:15 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Clearway Energy upgraded by CIBC with a new price target

    CIBC upgraded Clearway Energy from Neutral to Sector Outperform and set a new price target of $38.00

    12/17/25 10:50:37 AM ET
    $CWEN
    Electric Utilities: Central
    Utilities

    Bristol-Myers upgraded by BofA Securities with a new price target

    BofA Securities upgraded Bristol-Myers from Neutral to Buy and set a new price target of $61.00

    12/15/25 8:58:16 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bristol-Myers upgraded by Guggenheim with a new price target

    Guggenheim upgraded Bristol-Myers from Neutral to Buy and set a new price target of $62.00

    12/12/25 8:34:33 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive VP, Finance & CFO Scherger Stephen R. bought $1,006,982 worth of Ordinary Shares (121,065 units at $8.32) (SEC Form 4)

    4 - Amcor plc (0001748790) (Issuer)

    12/15/25 4:01:23 PM ET
    $AMCR
    Miscellaneous manufacturing industries
    Consumer Discretionary

    SVP CFO and Treasurer Lynch James Patrick bought $23,540 worth of shares (550 units at $42.80), increasing direct ownership by 14% to 4,619 units (SEC Form 4)

    4 - CALIFORNIA WATER SERVICE GROUP (0001035201) (Issuer)

    12/11/25 6:43:32 PM ET
    $CWT
    Water Supply
    Utilities

    Director Dietze Jane A bought $104,808 worth of Series A Perpetual Stretch Preferred Stock (1,100 units at $95.28), increasing direct ownership by 73% to 2,600 units (SEC Form 4)

    4 - Strategy Inc (0001050446) (Issuer)

    11/25/25 4:30:14 PM ET
    $STRC
    Wholesale Distributors
    Industrials

    $STRC
    $TCBP
    $TEAF
    $TGL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans

    Eliquis® (apixaban), the Nation's #1 Prescribed Oral Blood Thinner, Soon Available for Free to Medicaid Program Agreement Provides Tariff Relief for a 3-Year Period Bristol Myers Squibb (NYSE:BMY, "BMS")) today announced an agreement with the U.S. government to provide Eliquis® (apixaban), an oral anticoagulant relied upon by millions of Americans daily, for free to the Medicaid program and to donate more than seven tons of Eliquis active pharmaceutical ingredient (API) to ensure American supply chain resilience. The agreement is aligned with BMS's ongoing commitment to advancing cardiovascular health, improving patient outcomes and collaborating with policymakers on solutions that lower

    12/19/25 3:05:00 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    "For me, this is a return grounded in purpose" - Heather Domi

    In Alignment with CEO Michael Liebowitz's Vision for Douglas Elliman's New Era, Industry Leader and Strategic Luxury Advisor Heather Domi Returns to Douglas Elliman NEW YORK, Dec. 18, 2025 /PRNewswire/ -- Douglas Elliman Realty, the nation's leading luxury real estate brokerage, today announced the return of Heather L. Domi to the firm, marking a strategic homecoming and an exciting new chapter in a distinguished career spanning nearly 25 years in New York City and South Florida. She will lead the Heather Domi Team in Manhattan. Both the firm and its president and CEO, Michael S. Liebowitz, are excited to get the benefit of Domi's agent counsel, market insight, and industry advocacy as the c

    12/18/25 4:30:00 PM ET
    $DOUG
    Real Estate
    Finance

    Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts

    Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EST on Tuesday, February 3, 2026. The purpose of the call is to provide an update on Pfizer's results, as reflected in the company's Fourth Quarter and Full Year 2025 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance of the conference call. You can also listen

    12/18/25 10:00:00 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Reilly Heather Carter

    3 - abrdn National Municipal Income Fund (0000895574) (Issuer)

    12/19/25 4:11:20 PM ET
    $VFL
    Finance/Investors Services
    Finance

    President of Subsidiary Hartz Joseph L. sold $192,237 worth of UGI Common Stock (5,000 units at $38.45) and exercised 5,000 units of UGI Common Stock at a strike of $33.76 (SEC Form 4)

    4 - UGI CORP /PA/ (0000884614) (Issuer)

    12/18/25 5:06:39 PM ET
    $UGI
    Natural Gas Distribution
    Utilities

    Chief Financial Officer Mellet Celeste converted options into 2,128 units of Humana Common and covered exercise/tax liability with 1,222 units of Humana Common, increasing direct ownership by 3% to 28,454 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    12/17/25 3:12:53 PM ET
    $HUM
    Medical Specialities
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    SEC Filings

    View All

    FOXO Technologies Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

    12/19/25 5:20:43 PM ET
    $FOXO
    Life Insurance
    Finance

    SEC Form PRE 14C filed by FOXO Technologies Inc.

    PRE 14C - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

    12/19/25 5:15:24 PM ET
    $FOXO
    Life Insurance
    Finance

    SEC Form S-8 POS filed by Humana Inc.

    S-8 POS - HUMANA INC (0000049071) (Filer)

    12/19/25 4:57:12 PM ET
    $HUM
    Medical Specialities
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Leadership Updates

    Live Leadership Updates

    View All

    Douglas Elliman Appoints Natalie Passerini as Chief Marketing Officer

    Creative Marketing Leader Returns to Premiere Luxury Brokerage Amid Major Rebranding Initiative NEW YORK, Dec. 18, 2025 /PRNewswire/ -- Douglas Elliman Realty, the nation's leading luxury real estate brokerage, today announced that Natalie Passerini has joined the company as Chief Marketing Officer. Having served previously as the firm's Vice President of Marketing, Passerini returns as Elliman enters a pivotal period of brand evolution focused on elevating agent visibility, strengthening market leadership, and positioning the brand for long-term growth. She will oversee the strategic leadership of Douglas Elliman's corporate brand and fully integrated national marketing platform. Her mandat

    12/18/25 9:00:00 AM ET
    $DOUG
    Real Estate
    Finance

    Humana Announces Insurance Leadership Transition

    George Renaudin to Retire as Insurance Segment President by Q3 2026 Aaron Martin to Join as President of Medicare Advantage and Insurance Segment President Successor John Barger to Succeed Martin as President of Medicare Advantage Humana Inc. (NYSE:HUM) today announced that George Renaudin, Insurance Segment President and member of Humana's Enterprise Leadership Team, will retire by Q3 2026 following a successful 29-year career at the company. During this period, Renaudin played a pivotal role in establishing and growing Humana's Medicare Advantage and Medicaid programs, helping to build them into high-performing businesses and assembling a strong insurance leadership team. "George has co

    12/16/25 8:05:00 AM ET
    $HUM
    Medical Specialities
    Health Care

    Kenon Holdings Reports Q3 2025 Results and Additional Updates

    SINGAPORE, Dec. 3, 2025 /PRNewswire/ -- Kenon Holdings Ltd. (NYSE:KEN) (TASE: KEN) ("Kenon") announces its results for Q3 2025 and additional updates. Q3 and Recent Highlights Kenon In November 2025, Kenon sold a small portion of its OPC shares for gross proceeds of NIS 340 million (approximately $100 million).OPC In October 2025, OPC announced the financial closing and commencement of construction of the Basin Ranch Project, a gas-fired power plant project in Texas with an estimated 1.35 GW capacity (as described below), and CPV's entry into an agreement to acquire the remaining 30% interest in the Basin Ranch Project.In October 2025, OPC announced that CPV had entered into an agreement t

    12/3/25 8:36:00 AM ET
    $KEN
    Electric Utilities: Central
    Utilities

    $STRC
    $TCBP
    $TEAF
    $TGL
    Financials

    Live finance-specific insights

    View All

    Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts

    Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EST on Tuesday, February 3, 2026. The purpose of the call is to provide an update on Pfizer's results, as reflected in the company's Fourth Quarter and Full Year 2025 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance of the conference call. You can also listen

    12/18/25 10:00:00 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026

    Bristol Myers Squibb (NYSE:BMY) will announce results for the fourth quarter of 2025 on Thursday, February 5, 2026. Company executives will review financial results with the investment community during a conference call beginning at 8:00 a.m. ET. Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com. Materials related to the call will be available at http://investor.bms.com prior to the start of the conference call. A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes. About Bristol Myers Squibb: Transforming Patients' Lives Through Science At Bristol My

    12/18/25 6:59:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AM Best Affirms Credit Ratings of Humana Inc. and Its Subsidiaries

    AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) for the health and dental insurance subsidiaries of Humana Inc. (Humana) (headquartered in Louisville, KY) (NYSE:HUM). These subsidiaries collectively are referred to as Humana Health Group. In addition, AM Best has affirmed the Long-Term ICR of "bbb" (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of Humana Inc. (Humana). AM Best also has affirmed the Short-Term Issue Credit Rating of AMB-2 (Satisfactory) for Humana. The outlook of these Credit Ratings (ratings) is stable. (See below for a detailed listing of Humana Health Group

    12/16/25 5:31:00 PM ET
    $HUM
    Medical Specialities
    Health Care

    $STRC
    $TCBP
    $TEAF
    $TGL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Enservco Corporation

    SC 13D/A - Enservco Corp (0000319458) (Subject)

    12/10/24 4:00:16 PM ET
    $ENSV
    Oilfield Services/Equipment
    Energy

    Amendment: SEC Form SC 13G/A filed by Psychemedics Corporation

    SC 13G/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/6/24 9:18:20 PM ET
    $PMD
    Medical Specialities
    Health Care